DB15685

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2020
gptkbp:ATCCode J05AB16
gptkbp:bioavailability unknown
gptkbp:CASNumber 1809249-37-3
gptkbp:contraindication hypersensitivity to remdesivir
gptkbp:drugClass antiviral drug
gptkbp:eliminatedIn urine
feces
gptkbp:eliminationHalfLife 1 hour (remdesivir), 25 hours (GS-441524 metabolite)
gptkbp:excretion renal
gptkbp:hasAdministrationForm solution for infusion
powder for solution for infusion
gptkbp:hasBoxedWarning No
gptkbp:hasDrugType small molecule
gptkbp:hasInChIKey RWWYLEGWBNMMLJ-YSOARWBDSA-N
gptkbp:hasMolecularFormula C27H35N6O8P
gptkbp:hasPatentHolder gptkb:Gilead_Sciences
gptkbp:hasPregnancyCategoryAU gptkb:B2
gptkbp:hasPregnancyCategoryUS Not assigned
gptkbp:hasResearchUse investigational for other viral infections
gptkbp:hasSMILES CC(C)[C@@H](NC(=O)[C@@H](N)C(C)C)P(=O)(OCC1=CN(C2=CC=CC=C21)C3=NC=NC=C3)OCC4=CN(C5=CC=CC=C45)C6=NC=NC=C6
gptkbp:hasStorageCondition store below 30°C
gptkbp:hasUNII 53J0WS6OJ7
https://www.w3.org/2000/01/rdf-schema#label DB15685
gptkbp:indication gptkb:COVID-19
gptkb:Ebola_virus_infection
gptkbp:legalStatus prescription only
patented
gptkbp:manufacturer gptkb:Gilead_Sciences
gptkbp:mechanismOfAction RNA polymerase inhibitor
gptkbp:metabolism hepatic
gptkbp:molecularWeight 602.6 g/mol
gptkbp:name gptkb:Remdesivir
gptkbp:pregnancyCategory Not assigned
gptkbp:PubChem_CID gptkb:DB15685
121304016
CHEMBL2016761
58191791
D11960
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect nausea
elevated liver enzymes
hypersensitivity
gptkbp:status FDA approved
EMA approved
gptkbp:synonym gptkb:GS-5734
gptkbp:target RNA-dependent RNA polymerase
gptkbp:therapeuticArea gptkb:disease
gptkbp:bfsParent gptkb:Selpercatinib
gptkbp:bfsLayer 7